BeOne Medicines (ONC) EV to EBIT (2025 - 2026)
BeOne Medicines' (ONC) EV to EBIT was 29.37 for Q2 2026, down 28.6% from the prior quarter.
Powered by 
Analysis
BeOne Medicines (ONC) EV to EBIT (2025 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BeOne Medicines' EV to EBIT came in at 14.88; for FY2025, it came in at 65.15.
- Per Business Quant data, the three quarters before Q2 2026 came in at 41.12 (Q1 2026), 65.15 (Q4 2025) and 184.22 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | BeOne Medicines | 41.22 Bn | 22.75 Bn | 1.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.37 |
| Mar 31, 2026 | 41.12 |
| Dec 31, 2025 | 65.15 |
| Sep 30, 2025 | 184.22 |
API Access
BeOne Medicines EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ONC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "ONC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ONC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();